tetraethylammonium has been researched along with Carcinoma, Hepatocellular in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast, five hepatoma cell lines (Fao, Faza, H5, HTC and RHC1) showed either a decrease or an absence of OCT1 expression compared to normal hepatocytes; these hepatoma cells also displayed lower intracellular accumulation of tetraethylammonium (TEA), a well-known substrate for OCT1." | 1.30 | Differential expression of the polyspecific drug transporter OCT1 in rat hepatocarcinoma cells. ( Fardel, O; Guillouzo, A; Lecureur, V, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pelagalli, A | 1 |
| Nardelli, A | 1 |
| Fontanella, R | 1 |
| Zannetti, A | 1 |
| Lecureur, V | 1 |
| Guillouzo, A | 1 |
| Fardel, O | 1 |
2 other studies available for tetraethylammonium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
Topics: Aquaporin 1; Bone Marrow Cells; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Mo | 2016 |
Differential expression of the polyspecific drug transporter OCT1 in rat hepatocarcinoma cells.
Topics: Animals; Biological Transport; Carcinogens; Carcinoma, Hepatocellular; Carrier Proteins; Diethylnitr | 1998 |